BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chong ZX, Yeap SK, Ho WY. Unraveling the roles of miRNAs in regulating epithelial-to-mesenchymal transition (EMT) in osteosarcoma. Pharmacol Res 2021;172:105818. [PMID: 34400316 DOI: 10.1016/j.phrs.2021.105818] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Li T, Gao M, Wu Z, Yang J, Mo B, Yu S, Gong X, Liu J, Wang W, Luo S, Li R. Tantalum-Zirconium Co-Doped Metal-Organic Frameworks Sequentially Sensitize Radio-Radiodynamic-Immunotherapy for Metastatic Osteosarcoma. Adv Sci (Weinh) 2023;:e2206779. [PMID: 36739599 DOI: 10.1002/advs.202206779] [Reference Citation Analysis]
2 He G, Nie J, Liu X, Ding Z, Luo P, Liu Y, Zhang B, Wang R, Liu X, Hai Y, Chen D. Zinc oxide nanoparticles inhibit osteosarcoma metastasis by downregulating β-catenin via HIF-1α/BNIP3/LC3B-mediated mitophagy pathway. Bioactive Materials 2023;19:690-702. [DOI: 10.1016/j.bioactmat.2022.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tian Y, Liu R, Hou X, Gao Z, Liu X, Zhang W. SIRT2 promotes the viability, invasion and metastasis of osteosarcoma cells by inhibiting the degradation of Snail. Cell Death Dis 2022;13:935. [PMID: 36344502 DOI: 10.1038/s41419-022-05388-2] [Reference Citation Analysis]
4 Shen H, Yang H, Qileng A, Ma Y, Liang H, Meng J, Lei H, Liu Y, Liu W. Programmable readout sensor for microRNA: CRISPR/Cas12a-assisted multi-amplification strategy activated photoelectrochemistry-colorimetry detection. Sensors and Actuators B: Chemical 2022;371:132585. [DOI: 10.1016/j.snb.2022.132585] [Reference Citation Analysis]
5 Qiu Y, Yan H, Zheng R, Chen X, Wang Y, Yan Q, Ye Y, Zhang J, Han H, Wang K, Zhao Y, Huang L, Li X, Liu Z. cyy260 suppresses the proliferation, migration and tumor growth of osteosarcoma by targeting PDGFR-β signaling pathway. Chem Biol Interact 2022;367:110200. [PMID: 36170914 DOI: 10.1016/j.cbi.2022.110200] [Reference Citation Analysis]
6 Gao X, Gao B, Li S. Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma. Front Immunol 2022;13:1002742. [DOI: 10.3389/fimmu.2022.1002742] [Reference Citation Analysis]
7 Hashemi M, Moosavi MS, Abed HM, Dehghani M, Aalipour M, Heydari EA, Behroozaghdam M, Entezari M, Salimimoghadam S, Gunduz ES, Taheriazam A, Mirzaei S, Samarghandian S. Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy. Pharmacol Res 2022;184:106418. [PMID: 36038043 DOI: 10.1016/j.phrs.2022.106418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Xing X, Hu Y, Wang Y, Shao Y, Zou M, Zhang Z. No Effect on Tumorigenesis in MG63 Cells Induced by Co-Cultured Mesenchymal Stem Cells. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/4202439] [Reference Citation Analysis]
9 Huang H, Lu Q, Yuan X, Zhang P, Ye C, Wei M, Yang C, Zhang L, Huang Y, Luo X, Luo J. Andrographolide inhibits the growth of human osteosarcoma cells by suppressing Wnt/β-catenin, PI3K/AKT and NF-κB signaling pathways. Chemico-Biological Interactions 2022. [DOI: 10.1016/j.cbi.2022.110068] [Reference Citation Analysis]
10 Liu YY, Ding CZ, Chen JL, Wang ZS, Yang B, Wu XM. A Novel Small Molecular Inhibitor of DNMT1 Enhances the Antitumor Effect of Radiofrequency Ablation in Lung Squamous Cell Carcinoma Cells. Front Pharmacol 2022;13:863339. [PMID: 35401185 DOI: 10.3389/fphar.2022.863339] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Odri GA, Tchicaya-Bouanga J, Yoon DJY, Modrowski D. Metastatic Progression of Osteosarcomas: A Review of Current Knowledge of Environmental versus Oncogenic Drivers. Cancers (Basel) 2022;14:360. [PMID: 35053522 DOI: 10.3390/cancers14020360] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
12 Wang J, Huo C, Yin J, Tian L, Ma L, Wang D. Hypermethylation of the Promoter of miR-338-5p Mediates Aberrant Expression of ETS-1 and Is Correlated With Disease Severity Of Astrocytoma Patients. Front Oncol 2021;11:773644. [PMID: 34858853 DOI: 10.3389/fonc.2021.773644] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Hu Y, Liang D, Chen X, Chen L, Bai J, Li H, Yin C, Zhong W. [MiR-671-5p negatively regulates SMAD3 to inhibit migration and invasion of osteosarcoma cells]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:1562-8. [PMID: 34755673 DOI: 10.12122/j.issn.1673-4254.2021.10.16] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Hou CX, Wang L, Cai M, Meng Y, Tang YT, Zhu QH, Han W, Sun NN, Ma B, Hu Y, Ye JH. Sphk1 promotes salivary adenoid cystic carcinoma progression via PI3K/Akt signaling. Pathol Res Pract 2021;227:153620. [PMID: 34560416 DOI: 10.1016/j.prp.2021.153620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]